Who is the ideal patient for ritlecitinib, and are there any notable exclusions?

Featuring E. James Song, MD, FAAD | Co-Chief Medical Officer and Director of Clinical Research, Frontier Dermatology,Mill Creek, WA | Published October 01, 2024